These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21355090)

  • 1. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.
    Machlus KR; Cardenas JC; Church FC; Wolberg AS
    Blood; 2011 May; 117(18):4953-63. PubMed ID: 21355090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.
    Boulaftali Y; Lamrani L; Rouzaud MC; Loyau S; Jandrot-Perrus M; Bouton MC; Ho-Tin-Noé B
    Thromb Haemost; 2012 May; 107(5):962-71. PubMed ID: 22552380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice.
    Kwon I; Hong SY; Kim YD; Nam HS; Kang S; Yang SH; Heo JH
    PLoS One; 2013; 8(11):e81165. PubMed ID: 24260554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent Thrombolytic Effect of
    Martinez de Lizarrondo S; Gakuba C; Herbig BA; Repessé Y; Ali C; Denis CV; Lenting PJ; Touzé E; Diamond SL; Vivien D; Gauberti M
    Circulation; 2017 Aug; 136(7):646-660. PubMed ID: 28487393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor.
    Wang X; Smith PL; Hsu MY; Ogletree ML; Schumacher WA
    J Thromb Haemost; 2006 Feb; 4(2):403-10. PubMed ID: 16420573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity - a staphylokinase variant. An in-vivo study.
    Szemraj J; Stankiewicz A; Rozmyslowicz-Szermińska W; Mogielnicki A; Gromotowicz A; Buczko W; Oszajca K; Bartkowiak J; Chabielska E
    Thromb Haemost; 2007 Jun; 97(6):1037-45. PubMed ID: 17549308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfibrinogenemia alone does not affect the patency of microvascular anastomosis: clinical experience and animal study.
    Kuo YR; Jeng SF; Wu WS; Lin CJ; Sacks JM; Yang KD
    Ann Plast Surg; 2005 Apr; 54(4):435-41. PubMed ID: 15785287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cause-effect relation between hyperfibrinogenemia and vascular disease.
    Kerlin B; Cooley BC; Isermann BH; Hernandez I; Sood R; Zogg M; Hendrickson SB; Mosesson MW; Lord S; Weiler H
    Blood; 2004 Mar; 103(5):1728-34. PubMed ID: 14615369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis.
    Visconte C; Sainte-Marie M; Lorrain J; Millet L; O'Connor SE; Schaeffer P; Herbert JM
    J Thromb Haemost; 2004 Apr; 2(4):629-36. PubMed ID: 15102019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen and catheter-directed thrombolysis.
    Ross RL; Beck AW
    Semin Vasc Surg; 2014 Dec; 27(3-4):182-95. PubMed ID: 26073829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic and Antiplatelet Effects of a Novel Plasminogen Activator from the Venom of Gloydius Brevicaudus Viper.
    Zhang Z; Lin L; Zhang J; Zhang Q; Zhao N; Wu L; Chen J; Wu Z; Wu G; Lin J; Chen Y; Xu Y
    J Atheroscler Thromb; 2015; 22(10):1080-90. PubMed ID: 26004931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
    Sheffield WP; Eltringham-Smith LJ; Bhakta V; Gataiance S
    Thromb Haemost; 2012 May; 107(5):972-84. PubMed ID: 22370677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of active anticoagulant fraction and a fibrin(ogen)olytic serine protease from leaves of Clerodendrum colebrookianum, a traditional ethno-medicinal plant used to reduce hypertension.
    Gogoi D; Ramani S; Bhartari S; Chattopadhyay P; Mukherjee AK
    J Ethnopharmacol; 2019 Oct; 243():112099. PubMed ID: 31326559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
    Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic Modeling of Thrombolysis.
    Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide augments venous and arterial thrombosis in the mouse.
    Wang X
    Thromb Res; 2008; 123(2):355-60. PubMed ID: 18448153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-thrombotic efficacy of S007-867: Pre-clinical evaluation in experimental models of thrombosis in vivo and in vitro.
    Misra A; Prakash P; Aggarwal H; Dhankani P; Kumar S; Pandey CP; Pugh N; Bihan D; Barthwal MK; Farndale RW; Dikshit DK; Dikshit M
    Biochem Pharmacol; 2018 Feb; 148():288-297. PubMed ID: 29309758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.